Slate Medicines
Pre-clinicalSlate Medicines is a biotechnology company focused on developing next generation therapeutics targeting PACAP for the treatment and prevention of migraine and other headache disorders.
Founded
2021
Focus
AntibodiesBiologics
About
Slate Medicines is a biotechnology company focused on developing next generation therapeutics targeting PACAP for the treatment and prevention of migraine and other headache disorders.
Funding History
2Total raised: $100M
Series A$50MAtlas VentureJun 15, 2022
Seed$50MAtlas VentureJun 15, 2021
Company Info
TypePrivate
Founded2021
LocationCambridge, United States
StagePre-clinical
Contact
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile